TMCnet News
Tauriga Sciences Inc. Invited by Alibaba to be Exhibitor at the Inaugural Alibaba.com U.S. Supplements & Nutrition Online Tradeshow - July 7th-10th, 2020 NEW YORK, NYThe Company’s Participation as an Exhibitor is Free of Charge and the Company Gains Access to 1,000+ Interested Global Business Buyers NEW YORK, NY, June 01, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences Company, with proprietary CBD & CBG infused chewing gums and edibles product(s) as well as two ongoing Biotechnology initiatives, today announced that it has been invited by Chinese E-Commerce conglomerate Alibaba Group (“Alibaba”) to be an Exhibitor at the Inaugural Alibaba.com U.S. Supplements & Nutrition Online Tradeshow – July 7-10, 2020. Tauriga has been allocated an exclusive exhibitor spot (free of charge) to showcase its products and capabilities, Access to 1000+ interested Business Buyers looking to buy in bulk, and 1:1 networking and business meetings with Business Buyers. This invitation (free of charge) is due to Tauriga Sciences Inc. being designated, by Alibaba, as a “Top U.S. Seller in the Supplements & Nutrition Categories.” The Company’s dedicated portal page, on Alibaba.com, has generated substantial levels of interest and Buyer Inquiries, from a broad array of global prospective customers. The Company’s entire Tauri-Gum™ product line (CBD & CBG infused versions of its proprietary chewing gum), Tauri-Gummies™ product (CBD infused gum drops), and its product offering in partnership with OG Labs (Gummies: CBD + Collagen, CBD + Omega 3, CBD + Biotin, CBD + Multi Vitamins, and CBD + Fiber), will available for this Alibaba Online Tradeshow. ABOUT TAURIGA SCIENCES INC. Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives. The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment. The main product line, branded as Tauri-Gum™, consists of a proprieary supplement chewing gum that is both Kosher certified and Vegan formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate) & (CBG Infused Tauri-Gum™ Flavor: Peach-Lemon). The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at www.tauriga.com Complementary to the Company’s retail business, are its two ongoing biotechnology initiatives. The first one relates to the development of a Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed to help patients that are subjected to ongoing chemotherapy treatment). On March 18, 2020, the Company announced that it filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™. The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. The second one relates to a collaboration agreement with Aegea Biotechnologies Inc. for the co-development of a rapid, multiplexed, Novel Coronavirus (COVID-19) test with superior sensitivity and selectivity. The Company is headquartered in New York City and operates a regional office in Barcelona, Spain. In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York. DISCLAIMER -- Forward-Looking Statements Contact: CONTACT INFORMATION |